Serum miR-22 as Potential Non-Invasive Predictor of Poor Clinical Outcome in Newly Diagnosed, Uniformly Treated Patients With Diffuse Large B-Cell Lymphoma: An Explorative Pilot Study

Journal of Experimental and Clinical Cancer Research - United Kingdom
doi 10.1186/s13046-018-0768-5

Related search